Literature DB >> 6395825

Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases.

S Slopek, I Durlakowa, B Weber-Dabrowska, M Dabrowski, A Kucharewicz-Krukowska.   

Abstract

The results of phage therapy applied in further 150 cases of suppurative bacterial infections were analyzed. Positive therapeutic results were obtained in 137 cases (91.3%). The results obtained confirmed the previous findings on great effectiveness of bacteriophages in the treatment of septic infections, spontaneous or postoperative, caused by pyo genic Staphylococci, Klebsiella, Escherichia, Proteus and Pseudomonas.

Entities:  

Mesh：

Year:  1984        PMID： 6395825

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN： 0004-069X            Impact factor:   4.291


  14 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  The use of bacteriophages in eliminating polyresistant strains of Staphylococcus aureus and Streptococcus agalactiae.

Authors:  Z Brnáková; J Farkasovská; A Godány
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

3.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

4.  Isolation and characterisation of KP34--a novel φKMV-like bacteriophage for Klebsiella pneumoniae.

Authors:  Zuzanna Drulis-Kawa; Paweł Mackiewicz; Agata Kęsik-Szeloch; Ewa Maciaszczyk-Dziubinska; Beata Weber-Dąbrowska; Agata Dorotkiewicz-Jach; Daria Augustyniak; Grażyna Majkowska-Skrobek; Tomasz Bocer; Joanna Empel; Andrew M Kropinski
Journal:  Appl Microbiol Biotechnol       Date:  2011-02-16       Impact factor: 4.813

5.  Prospects for Biocontrol of Vibrio parahaemolyticus Contamination in Blue Mussels (Mytilus edulus)-A Year-Long Study.

Authors:  Bukola A Onarinde; Ronald A Dixon
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

6.  Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria.

Authors:  Masoud Sabouri Ghannad; Avid Mohammadi
Journal:  Iran J Basic Med Sci       Date:  2012-03       Impact factor: 2.699

Review 7.  Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.

Authors:  Zuzanna Drulis-Kawa; Grazyna Majkowska-Skrobek; Barbara Maciejewska; Anne-Sophie Delattre; Rob Lavigne
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

8.  Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase.

Authors:  Chun-Ru Hsu; Tzu-Lung Lin; Yi-Jiun Pan; Pei-Fang Hsieh; Jin-Town Wang
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

9.  Characterization of Five Podoviridae Phages Infecting Citrobacter freundii.

Authors:  Sana Hamdi; Geneviève M Rousseau; Simon J Labrie; Rim S Kourda; Denise M Tremblay; Sylvain Moineau; Karim B Slama
Journal:  Front Microbiol       Date:  2016-06-29       Impact factor: 5.640

10.  Two T7-like Bacteriophages, K5-2 and K5-4, Each Encodes Two Capsule Depolymerases: Isolation and Functional Characterization.

Authors:  Pei-Fang Hsieh; Hsiao-Hsuan Lin; Tzu-Lung Lin; Yi-Yin Chen; Jin-Town Wang
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.